Outset Medical, Inc. is a medical technology company. The Company offers Tablo Hemodialysis System (Tablo), which is a single enterprise solution for hemodialysis, comprised of a compact console with integrated water purification, on-demand dialysate production and advanced software and connectivity capabilities. The Company designed Tablo from the ground up to be a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by virtually anyone. The Tablo system comprises components, which include Tablo Console, Tablo Cartridge and Tablo Data Ecosystem. Tablo Console is a compact, mobile and versatile machine consisting of an integrated water purification, on-demand dialysate production system and touchscreen interface with 3D animations. It also offers various key platforms, such as TabloHub, a customer-facing portal; MyTablo, a patient-facing portal, and TabloDash, an internal data analytics platform.
BörsenkürzelOM
Name des UnternehmensOutset Medical Inc
IPO-datumSep 15, 2020
CEOMs. Leslie L. Trigg
Anzahl der mitarbeiter354
WertpapierartOrdinary Share
GeschäftsjahresendeSep 15
Addresse3052 Orchard Drive
StadtSAN JOSE
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl95134
Telefon16692318200
Websitehttps://outsetmedical.com/
BörsenkürzelOM
IPO-datumSep 15, 2020
CEOMs. Leslie L. Trigg
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten